Skip to content
Monday, March 1, 2021
COA Pharmacy

COA Pharmacy

Community Oncology Pharmacy Association

  • About
    • Mission & Purpose
    • COPA Advisory Board
  • Partners
    • Supporting COPA
    • Athenex
    • BeiGene
    • Cardinal Health
    • Incyte
    • ION Solutions
    • Janssen Oncology
    • MorphoSys
    • Oncopeptides
    • Advertising Information
  • Resources
    • Patient PBM Experiences
    • Latest News
    • Payers
      • Part B / DMERC
      • Part D
    • State Laws
      • CSRO Legislative Map Tool
        • Step Therapy
        • Non-Medical Switching
        • Accumulator Adjustment Program
        • Uniform Prior Authorization
      • J & J Interactive State Tool
        • Medicaid Expansion
        • State Pharmaceutical Assistance Programs (SAPs)
        • Low-Income Subsidy (LIS) Eligibility Information
        • State Health Insurance Assistance Programs (SHIPs)
        • Standard Prior Authorization (PA) Forms
        • National Foundations & Other Nonprofit Resources
        • Oral Parity Laws
        • Advocacy Connector
        • Biosimilar Legislation
        • Continuity of Care
        • State Legislature Resources
      • Step Therapy Legislation By State
      • Pharmacy Dispensing Regulations
    • USP 797/800
    • Patients
  • Membership
    • About Membership
    • Become a Member
    • Member Log In
  • ACHC Accreditation
  • COAnalyzer.Net
  • Studies & Publications
  • Log In >>

Archived News

Archived News 

Why CVS Is Giving Plans A New Tool To Target High Launch Prices

September 17, 2018 copaadmin

Dr. Robert Dubois of the National Pharmaceutical Council (NPC) has expressed his concerns about CVS Health’s new service offering that allows

Read more
Archived News 

Trump administration moves to give Medicare drug plans more control over their offerings

August 30, 2018 copaadmin

The Trump administration moved Wednesday to give Medicare drug plans more choices in the products they can offer patients, in

Read more
Archived News 

Will CMS Pop the Gross-to-Net Bubble in Medicare Part D With Point-of-Sale Rebates?

November 21, 2017 copaadmin

Last week, the Centers for Medicare & Medicaid Services (CMS) released its 713-page proposed policy changes and updates for the

Read more
Archived News 

Lewis Carroll and the Pricing of Pharmaceuticals

September 21, 2017September 25, 2017 copaadmin

Imagine a pharmaceutical market designed by Lewis Carroll’s Mad Hatter. In contrast to almost every other market, he might begin

Read more
Archived News 

Pharmacists Should Have Plans in Place for Disasters

September 15, 2017September 25, 2017 copaadmin

Disasters like major storms, earthquakes, wildfires, and terrorist actions happen. Pharmacists should have plans in place that allow them to

Read more
Archived News 

COA Representatives Join Congressional Briefing on Personalized Medicine and the Future of Cancer Care Delivery and Payment

September 14, 2017September 25, 2017 copaadmin

Representatives from the Community Oncology Alliance (COA) joined other cancer stakeholders and policymakers on Capitol Hill today for a briefing

Read more
Archived News 

It’s time to reform accessibility to prescription drugs

September 13, 2017September 25, 2017 copaadmin

Too many Americans can’t readily access or afford their prescription drugs. Pharmacy benefit managers (PBMs) play a central role in

Read more
Archived News 

Cancer drugs’ high prices not justified by cost of development, study contends

September 13, 2017September 25, 2017 copaadmin

(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D)

Read more
Archived News 

Cancer immunotherapy proves itself in earlier-stage disease

September 11, 2017September 25, 2017 copaadmin

MADRID (Reuters) – Cancer doctors are widening the net for immunotherapy, a hot new class of drugs that enlist the

Read more
Archived News 

Clovis CEO deems new Rubraca data ‘better’ than its PARP rivals. Is it enough?

September 8, 2017September 25, 2017 copaadmin

Clovis Oncology may be the middle child in the new wave of ovarian cancer treatments, but it’s hoping some new

Read more
  • ← Previous

News

Latest News 

Pfizer Lawsuit Tests Crackdown on Drugmakers Picking Up Copays

February 26, 2021 copaadmin

A Pfizer Inc. challenge to an enforcement push against drug company and charity collaborations is testing the bounds of the

Latest News 

Is FDA Getting It Right on Cancer Drug Approvals?

February 26, 2021 copaadmin

Archived News

Archived News 

Why CVS Is Giving Plans A New Tool To Target High Launch Prices

September 17, 2018 copaadmin

Dr. Robert Dubois of the National Pharmaceutical Council (NPC) has expressed his concerns about CVS Health’s new service offering that allows

Archived News 

Trump administration moves to give Medicare drug plans more control over their offerings

August 30, 2018 copaadmin

Login Status

Forgot?  Register
                                     
                                     
The Community Oncology Pharmacy Association (COPA) was formed in response to the increasing number of community cancer clinics dispensing oral cancer drugs and ancillary therapies. COPA is a non-profit entity, under the direction of COA, that has established national quality standards in partnership with ACHC and will be providing information, education, and resources, enhancing information exchange, and helping advocate for the patient-centric model of integrated, high quality cancer care.

 

© Copyright Community Oncology Alliance | All Rights Reserved | Terms and Conditions | Privacy Policy

For more information, please contact:

Ricky Newton, CPA
Chief Financial & Operating Officer
P: 757-639-4855
E: [email protected]

760 Lynnhaven Parkway
Suite 150
Virginia Beach, VA 23452